Global Icodextrin CAS 337376 15 5 Market by Type (7.5ï¼… Icodextrin, 4ï¼… Icodextrin), By Application (Ambulatory Peritoneal Dialysis (CAPD), Automatic Peritoneal Dialysis (APD), Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

The Global Icodextrin Market size is projected to grow at a CAGR of 3.8% from 2021-2028. North America will continue to be the largest regional market for Icodextrins, accounting for 37% of the total demand in 2028. In Europe, the Asia Pacific, and Middle East & Africa regions, it is expected that Icodextrin consumption would register a positive growth rate over the forecast period on account of the increasing prevalence of chronic kidney diseases across these regions.

Icodextrin, also known as cyclic dextrin, is a type of carbohydrate that has the ability to absorb water and increase in volume. Icodextrin can be used for medical purposes because it provides energy without increasing blood sugar levels or raising insulin production. It is preferred by people who are managing diabetes because it contains low caloric value but high nutritional benefits.

Icodextrin is a glucose polymer that comprises short chains having dextrose units. Icodextrin is used as an intravenous (IV) fluid therapy for patients who require large amounts of fluids but are unable to take oral medications or nutrients due to critical illness. ï¼…the properties of this water-soluble compound make it more suitable than free sugar solution in the IV route for administering nutritive substances because there is no osmotic load on renal tubules with its use.

On the basis of Type, the global Icodextrin market is segmented into ï¼…, ï¼…, and ï¼….

On the basis of Application, the global Icodextrin market is segmented into Ambulatory Peritoneal Dialysis (CAPD), Automatic Peritoneal Dialysis (APD), and Others.

Ambulatory Peritoneal Dialysis (CAPD):

Icodextrin is used in Ambulatory Peritoneal Dialysis (CAPD) to provide volume for the peritoneum with minimal insulin. Icodextrin may increase glucose availability, but it does not stimulate endogenous insulin secretion or affect the hepatic metabolism of exogenous substrates at normal physiologic concentrations. ） It has no toxic effects on kidney function and can be given by mouth or intravenously followed by oral administration after its biological half-life demonstrated that it had a duration of action equal to about three hours when administered orally. The intended effect is an improvement in glycemic control without entailing any risk of hypoglycemia if blood glucose levels are properly monitored during treatment with iCodextrin.

Automatic Peritoneal Dialysis (APD):

Icodextrin is a glucose polymer consisting of amylopectin and dextrins. It helps to control blood sugar levels in the body, as it slows down carbohydrate absorption. The procedure of use Icodextrin in Automatic Peritoneal Dialysis (APD) includes insertion into a catheter which is attached to an infusion port; installation after irrigation with dialysate from bag or container through tubing connected to the patient's peritoneum for continuous drainage out fluid retention from the abdomen via gravity flow system during APD treatment.

On the basis of Region, the global Icodextrin market is segmented into North America (the United States, Canada, and Mexico), Europe (Germany, France, Russia, and the UK), Asia-Pacific (India China, Japan, and South Korea) & LAMEA (" Latin America" through Brazil; "Middle East Africa" through Saudi Arabia). The European region holds a major share in the global Icodextrin market and has witnessed a significant growth rate during the last few years due to increasing demand for dialysis type of treatment across this region. North America & Latin America are expected to show an excellent CAGR over the next five years owing to the high prevalence of chronic kidney disease (CKD) along with the availability of advanced healthcare infrastructure. Asia Pacific is projected as one of the fastest-growing regions in terms of revenue generation from 2017-2028 primarily driven by rapid economic development coupled with a rising geriatric population base which directly results in an increase in the prevalence of CKD.

Growth Factors For The Global Icodextrin Market:

The rising geriatric population throughout the globe is expected to be one of the prominent drivers for the global Icodextrin market. Furthermore, increasing healthcare expenditure in developing economies that are gaining popularity across major geographies such as North America and Europe will also drive the growth of this market over the forecast period. The R&D investments, rising focus on disease treatment, and launch of advanced products drive the growth rate in 2021 - 2028.

Up Market Research published a new report titled “Icodextrin CAS 337376 15 5 Market research report which is segmented by Types (7.5ï¼… Icodextrin, 4ï¼… Icodextrin), By Applications (Ambulatory Peritoneal Dialysis (CAPD), Automatic Peritoneal Dialysis (APD), Others), By Players/Companies Baxter, FZBIOTECH”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Icodextrin CAS 337376 15 5 Market Report Segments:

The market is segmented by Type 7.5ï¼… Icodextrin, 4ï¼… Icodextrin and By Application Ambulatory Peritoneal Dialysis (CAPD), Automatic Peritoneal Dialysis (APD), Others.

Some of the companies that are profiled in this report are:

1. Baxter
2. FZBIOTECH

Icodextrin CAS 337376 15 5 Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Icodextrin CAS 337376 15 5 Market

Overview of the regional outlook of the Icodextrin CAS 337376 15 5 Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Icodextrin CAS 337376 15 5 Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Icodextrin CAS 337376 15 5 Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.
6. By Type:

                1. 7.5ï¼… Icodextrin

                2. 4ï¼… Icodextrin

                1. Ambulatory Peritoneal Dialysis (CAPD)

                2. Automatic Peritoneal Dialysis (APD)

                3. Others

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Icodextrin CAS 337376 15 5 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Icodextrin CAS 337376 15 5 Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.